India's drug regulator all set to take call on Bharat Biotech’s pediatric COVID vaccine

The subject expert committee of India's drug regulator is all set to take a call on Bharat Biotech’s pediatric COVID vaccine. Bharat biotech, which completed its phase-ii and iii trials of Covaxin's pediatric jab has submitted the data to the central drugs standard control organization for its verification and subsequent approval.